Drug-induced sleep endoscopy (DISE), also known as sleep nasendoscopy (SNE), is a minimally invasive surgical procedure. It is a diagnostic tool used for studying the airway in a sleeping (sedated) patient with obstructive sleep apnea (OSA). Drug induced sleep endoscopy, also known as DISE or DISE-PAP, is a diagnostic procedure to evaluate the upper airway of patients suffering from snoring and obstructive sleep apnea.
DISE addresses this challenge by mimicking natural sleep patterns while allowing for direct observation of the upper airway. The procedure utilizes carefully selected sedative drugs to induce a sleep-like state that closely resembles natural sleep in terms of muscle relaxation and airway dynamics. Insider Monkey: Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Call Transcript I think if you ask a lot of the ENTs and we work with our physicians to make sure that is true, they much rather do the implant procedure to move forward rather than picking up a couple of hundred ...
dise procedure inspire, How are leading companies turning DISE requirements into execution? Join our webcast to hear how public company leaders are driving DISE implementation, addressing data and reporting challenges, and positioning their organizations to meet upcoming requirements with confidence. DISE is a necessary tool nowadays in the armamentarium of the sleep surgeon, allowing thorough and targeted evaluation of dynamic pharyngeal obstruction in the sleeping patient. Drug induced sleep endoscopy (DISE) has been established as a useful tool that can help determine patient candidacy for many of these interventions by way of assessing the anatomy and collapsibility of upper airway structures (Cheong et al, 2021).
